NCT05512871

Brief Summary

This study aims to explore: (1) the relationship between lifestyle factors (eating, movement behaviour, sleep and stress) and glycaemic profile, and (2) the feasibility of delivering lifestyle intervention through the proposed mHealth strategy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2022

Completed
29 days until next milestone

First Posted

Study publicly available on registry

August 23, 2022

Completed
27 days until next milestone

Study Start

First participant enrolled

September 19, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 28, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 28, 2023

Completed
Last Updated

November 8, 2023

Status Verified

November 1, 2023

Enrollment Period

7 months

First QC Date

July 25, 2022

Last Update Submit

November 7, 2023

Conditions

Keywords

Healthy women, Gestational Diabetes Mellitus history, GDM history, mobile health apps

Outcome Measures

Primary Outcomes (1)

  • Mobile health application feasibility

    Number of participants that show a change in lifestyle behaviour through the mobile health application usage.

    10 weeks

Secondary Outcomes (8)

  • Oral glucose tolerance test (OGTT) measurements

    Week -1 and 10

  • Change in sleep quality as assessed by the Oura Ring Sleep Score.

    10 weeks

  • Change in daily physical activity levels as assessed by the Oura Ring Activity Score.

    10 weeks

  • Postprandial glucose

    14 days

  • Change in quality of life

    Week -1 and 10

  • +3 more secondary outcomes

Study Arms (2)

Group 1 (Intervention group)

EXPERIMENTAL

Group 1 (Intervention group) :Oura ring with Oura App + HealthifySG App (receive lifestyle interventions via HealthifySG App)

Behavioral: Personalized mHealth intervention to promote short-term metabolic and mental health among women with a history of Gestational Diabetes Mellitus (GDM)

Group 2 (Control group)

OTHER

Group 2 (Control group) : Oura ring with Oura App alone (without lifestyle interventions)

Behavioral: Personalized mHealth intervention to promote short-term metabolic and mental health among women with a history of Gestational Diabetes Mellitus (GDM)

Interventions

The study aim to conduct lifestyle intervention trials to examine the feasibility, efficacy, and cost-effectiveness of the mHealth approach in preventing them from developing Type 2 Diabetes in the future. This pilot study will primarily aim to determine the feasibility of our intervention approaches as well as enhance health literacy and promote healthy lifestyle in the study participants. In the longer term, we hope that the proposed mHealth intervention can be translated to include women from the community setting and involve wider healthcare setting to come together and reduce the burden of Type 2 Diabetes in Singapore.

Group 1 (Intervention group)Group 2 (Control group)

Eligibility Criteria

Age21 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsHealthy women volunteers who has given birth previously and with a history of GDM within the last 5 years (Post partum 13 weeks and beyond).
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy female volunteers (age 21-45 years)
  • A history of GDM in the past 5 years
  • Not planning to conceive during the study period
  • Not performing full breastfeeding during the study period
  • Own a smart phone(mobile phone) compatible with study App (Android v10 and above)
  • Proficient in English language
  • Plan to stay in Singapore for the next 1 year
  • Willing to comply to study protocol
  • Able to provide a written informed consent

You may not qualify if:

  • Current and/or previous diagnosis of diabetes except GDM
  • Currently pregnant
  • Given birth within last 12 weeks
  • Following special diet or dietary restriction
  • Experiencing severely limited mobility (e.g. wheelchair bound, need walking aid etc.)
  • Diagnosed with malnutrition, eating disorder, severe insomnia
  • Diagnosed with cancers, unstable heart related diseases, severe kidney disease
  • Diagnosed with severe unstable mental conditions, dementia or cognitive impairment
  • Alcohol or drug abuse
  • Medications known to influence glucose metabolism e.g. peroral corticosteroids

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Human Development Research Centre (Hdrc)

Singapore, 117597, Singapore

Location

Related Publications (1)

  • Liew SJ, Soon CS, Chooi YC, Tint MT, Eriksson JG. A holistic approach to preventing type 2 diabetes in Asian women with a history of gestational diabetes mellitus: a feasibility study and pilot randomized controlled trial. Front Clin Diabetes Healthc. 2023 Sep 28;4:1251411. doi: 10.3389/fcdhc.2023.1251411. eCollection 2023.

MeSH Terms

Conditions

Diabetes, Gestational

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
60-80 female subjects will be randomized to either Group 1 (Intervention group) or Group 2 (Control group) based on 1:1 allocation. HealthifySG App will only be installed on the phones of subjects for Group 1(Intervention group).
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The study is a parallel 2-arm, single-centre randomized controlled trial based on 1:1 allocation ratio: Group1 (Intervention group) - Oura ring with Oura App + HealthifySG App (receive lifestyle interventions via HealthifySG App) Group 2 (Control group) - Oura ring with Oura App alone (without lifestyle interventions)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Executive Director & Programme Director (Human Development)

Study Record Dates

First Submitted

July 25, 2022

First Posted

August 23, 2022

Study Start

September 19, 2022

Primary Completion

April 28, 2023

Study Completion

April 28, 2023

Last Updated

November 8, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations